Carl Schaper, an insider and also director of the popular company Q2 Holdings Inc made transaction. He unloaded 20,000 shares of the firm with the transaction having a total value of $737,200 US Dollars – which is based on a stock price of $36.9 for every share. In the last 30 days, he also unloaded 75 shares with a total value $3,034 USD. Carl Schaper owns 0.05% of the -company’s market cap or 22,274 shares.
Biogen Inc., a biopharmaceutical company, discovers, develops, makes, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company has market cap of $71.66 billion. The firm offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis ; FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It has a 20.82 P/E ratio. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies.
Q2 Holdings, Inc. provides cloud-based digital banking solutions to regional and community financial institutions in the United States. The company has market cap of $1.63 billion. The firm offers Q2online, a browser digital banking solution that delivers RCFI-branded digital banking capabilities; Q2 Risk & Fraud Analytics, a security analytics solution for clients to detect and block suspect transactions in digital banking solutions; Q2 Corporate to support RCFIs to attract and retain larger commercial accounts; and Q2 SMART, a targeting and messaging platform that allows clients to analyze account holder data. It currently has negative earnings. It also provides Q2mobility App to access, engage, and complete banking transactions, such as adding and managing payees, transferring funds, executing single or recurring payments, viewing e-statements or check images, and managing other general banking services through mobile and tablet devices; Q2mobile Remote Deposit Capture, a partnered solution that allows remote check deposit capture; and Q2text, a mobile solution, which enables digital banking activities through the text messaging function of the device.
Among 15 analysts covering Q2 Holdings Inc (NYSE:QTWO), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Q2 Holdings Inc has $50.0 highest and $25 lowest target. $42.83’s average target is 9.68% above currents $39.05 stock price. Q2 Holdings Inc had 30 analyst reports since August 4, 2015 according to SRatingsIntel. Needham maintained the shares of QTWO in report on Friday, February 17 with “Buy” rating. The stock has “Outperform” rating by RBC Capital Markets on Friday, August 5. The stock has “Buy” rating by Needham on Tuesday, June 21. Canaccord Genuity downgraded the shares of QTWO in report on Thursday, November 2 to “Hold” rating. RBC Capital Markets maintained Q2 Holdings, Inc. (NYSE:QTWO) rating on Friday, August 7. RBC Capital Markets has “Outperform” rating and $30 target. Suntrust Robinson initiated Q2 Holdings, Inc. (NYSE:QTWO) on Tuesday, June 27 with “Buy” rating. The rating was maintained by Canaccord Genuity on Sunday, July 30 with “Buy”. The rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, November 3. The stock of Q2 Holdings, Inc. (NYSE:QTWO) has “Buy” rating given on Friday, August 7 by Canaccord Genuity. The stock has “Hold” rating by KeyBanc Capital Markets on Thursday, October 26.
Since August 7, 2017, it had 0 insider buys, and 16 insider sales for $9.81 million activity. Breeden John E also sold $394,200 worth of Q2 Holdings, Inc. (NYSE:QTWO) on Wednesday, August 23. Flake Matthew P had sold 30,000 shares worth $1.19M. Schaper Carl James also sold $788,200 worth of Q2 Holdings, Inc. (NYSE:QTWO) shares. Benton Barry G sold $153,072 worth of Q2 Holdings, Inc. (NYSE:QTWO) on Monday, August 7. 10,560 shares valued at $408,871 were sold by Seale R. H. on Tuesday, December 12. Wittenburg Odus Edward Jr sold $847,663 worth of stock or 21,250 shares. On Friday, September 1 the insider Blue Adam D sold $1.39M.
Analysts await Q2 Holdings, Inc. (NYSE:QTWO) to report earnings on February, 21. They expect $-0.11 EPS, up 8.33% or $0.01 from last year’s $-0.12 per share. After $-0.10 actual EPS reported by Q2 Holdings, Inc. for the previous quarter, Wall Street now forecasts 10.00% negative EPS growth.
The stock decreased 0.89% or $0.35 during the last trading session, reaching $39.05. About 81,613 shares traded. Q2 Holdings, Inc. (NYSE:QTWO) has risen 76.19% since January 4, 2017 and is uptrending. It has outperformed by 59.49% the S&P500.
Investors sentiment decreased to 1.45 in 2017 Q3. Its down 0.16, from 1.61 in 2017Q2. It worsened, as 8 investors sold Q2 Holdings, Inc. shares while 41 reduced holdings. 26 funds opened positions while 45 raised stakes. 33.93 million shares or 0.34% less from 34.05 million shares in 2017Q2 were reported. Swiss Bankshares has 50,500 shares. Oppenheimer Asset Mgmt Inc has 2,709 shares for 0% of their portfolio. Putnam Invs Llc reported 43,924 shares. Neuberger Berman Group Ltd Liability Corp accumulated 0% or 37,500 shares. Citigroup owns 830 shares. Great West Life Assurance Can reported 0% in Q2 Holdings, Inc. (NYSE:QTWO). Loring Wolcott & Coolidge Fiduciary Advsrs Limited Liability Partnership Ma invested 0% in Q2 Holdings, Inc. (NYSE:QTWO). Massachusetts Finance Service Commerce Ma stated it has 447,469 shares. Art Limited Liability Com reported 11,500 shares stake. Wells Fargo And Company Mn invested in 1.50M shares or 0.02% of the stock. 58,550 were reported by Mutual Of America Cap Mgmt Ltd Liability. Ameritas Investment reported 2,751 shares. National Bank Of America De holds 0% or 76,508 shares in its portfolio. Bnp Paribas Arbitrage Sa has 3,219 shares for 0% of their portfolio. Symmetry Peak Management Limited Liability Corp invested in 25,000 shares or 0.12% of the stock.
Sarissa Capital Management Lp holds 37.1% of its portfolio in Biogen Inc. for 383,858 shares. Healthinvest Partners Ab owns 20,400 shares or 7.46% of their US portfolio. Moreover, Terril Brothers Inc. has 5.81% invested in the company for 57,915 shares. The Massachusetts-based Tekla Capital Management Llc has invested 5.48% in the stock. Waverton Investment Management Ltd, a United Kingdom-based fund reported 272,602 shares.
The stock decreased 0.29% or $0.995 during the last trading session, reaching $338.855. About 546,618 shares traded. Biogen Inc. (BIIB) has risen 4.94% since January 4, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.
Ratings analysis reveals 71% of Biogen’s analysts are positive. Out of 7 Wall Street analysts rating Biogen, 5 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $290.0 while the high is $386.0. The stock’s average target of $324.67 is -4.19% below today’s ($338.855) share price. BIIB was included in 7 notes of analysts from September 6, 2016. Citigroup upgraded the stock to “Buy” rating in Tuesday, February 7 report. The firm has “Overweight” rating by Piper Jaffray given on Monday, November 7. As per Thursday, December 29, the company rating was maintained by Raymond James. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Outperform” rating by Leerink Swann on Monday, November 7. The firm has “Hold” rating given on Friday, December 9 by Stifel Nicolaus. Mizuho initiated Biogen Inc. (NASDAQ:BIIB) on Tuesday, November 8 with “Buy” rating. The rating was downgraded by Jefferies to “Hold” on Tuesday, September 6.
Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on January, 25. They expect $5.52 earnings per share, up 9.52% or $0.48 from last year’s $5.04 per share. BIIB’s profit will be $1.17 billion for 15.35 P/E if the $5.52 EPS becomes a reality. After $6.31 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -12.52% negative EPS growth.